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Abstract
Weight loss can have substantial health beneﬁts for overweight or obese persons; however, the ratio of fat:lean tissue
loss may be more important. We aimed to determine how daily exercise (resistance and/or aerobic) and a hypoenergetic
diet varying in protein and calcium content from dairy foods would affect the composition of weight lost in otherwise
healthy, premenopausal, overweight, and obese women. Ninety participants were randomized to 3 groups (n = 30/group):
high protein, high dairy (HPHD), adequate protein, medium dairy (APMD), and adequate protein, low dairy (APLD) differing
in the quantity of total dietary protein and dairy food-source protein consumed: 30 and 15%, 15 and 7.5%, or 15 and ,2%
of energy, respectively. Body composition was measured by DXA at 0, 8, and 16 wk and MRI (n = 39) to assess visceral
adipose tissue (VAT) volume at 0 and 16 wk. All groups lost body weight (P , 0.05) and fat (P , 0.01); however, fat loss
during wk 8–16 was greater in the HPHD group than in the APMD and APLD groups (P , 0.05). The HPHD group gained
lean tissue with a greater increase during 8–16 wk than the APMD group, which maintained lean mass and the APLD
group, which lost lean mass (P , 0.05). The HPHD group also lost more VAT as assessed by MRI (P , 0.05) and trunk fat
as assessed by DXA (P , 0.005) than the APLD group. The reduction in VAT in all groups was correlated with intakes of
calcium (r = 0.40; P , 0.05) and protein (r = 0.32; P , 0.05). Therefore, diet- and exercise-induced weight loss with higher
protein and increased dairy product intakes promotes more favorable body composition changes in women characterized
by greater total and visceral fat loss and lean mass gain. J. Nutr. 141: 1626–1634, 2011.
Introduction
Weight loss in overweight and obese persons through diet and/or
exercise can confer a host of metabolic beneﬁts (1,2). Although
energy restriction alone often leads to weight loss, the tissue
composition of the loss includes lean tissue (3–5), which could
have deleterious metabolic consequences. The loss of lean tissue
with weight loss may be responsible for the tendency toward
a plateau in weight loss during, or weight regain following, a
weight loss program (6,7). Moreover, skeletal muscle plays a
number of important roles in the regulation of glycemia (8) and
lipidemia (9), suggesting that the loss of this tissue may have
adverse effects on long-term metabolic health (10). We propose
that weight loss strategies should be focused on the tissue
composition of the weight lost and not based merely on scale
weight; instead, weight loss interventions should be aimed
toward loss of fat, especially visceral fat, and the preservation of
muscle mass.
The optimal dietary macronutrient composition to achieve
weight loss remains controversial. Several large clinical trials
have shown that adherence to an energy-restricted diet, not the
macronutrient composition per se, seems to be the primary
factor driving weight loss (11–13). However, none of these
studies addressed the tissue composition of the participants’
weight loss, especially lean mass loss, the sparing of which
would actually reduce weight lost; thus, in these trials, the
investigators potentially missed important effects of the different
diets beyond weight change (11–13). For example, higher
protein, lower carbohydrate, energy-restricted diets have been
shown to help offset the lean mass loss observed with conven-
tional (;55% of energy intake) carbohydrate diets (14–16), and
pairing higher protein intakes with exercise, especially resistance
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during weight loss (17–19). Insofar as weight maintenance is
concerned, individuals who consumed higher protein (and re-
duced the glycemic index of their dietary carbohydrates) fol-
lowing 8 wk of weight loss were better able to maintain their
initial loss for an additional 26 wk compared to those who
consumed maintenance diets lower in protein (20).
Trials in humans have linked the consumption of dairy foods
and dairy-derived calcium to greater weight loss and fat mass
loss (21–25), a mechanism that is supported by in vitro ex-
perimental studies for the antiadipogenic effects of dairy foods
(26–28). In young, recreationally active men and women, we
observed an advantage of consuming low-fat milk with resis-
tance exercise in promoting lean mass gains both acutely (29)
and over time in conjunction with fat mass loss, despite par-
ticipants being in positive energy balance (30,31). Thus, as a
strategy for weight loss and lean mass retention, dairy foods
would appear advantageous.
In this study, we aimed to achieve weight loss with a high
ratio of fat:lean mass loss. This pattern is important not only for
short-term efﬁcacy but also for long-term metabolic health and
body weight maintenance (6,7). Our approach was multifaceted
and incorporated aspects shown in previous programs to help
preserve or increase muscle mass and yet still promote fat mass
loss (30–32). We combined energy restriction, higher dietary
protein (lower carbohydrate), increased intakes of dairy foods,
and exercise (aerobic and resistance) into one program. Our
speciﬁc objectives were to test: the effect of consuming high-
dairy protein and calcium compared to a typical dietary pattern,
the effect of doubling the consumption of dietary (and dairy)
protein as a percent of total energy intake, and the effect of pro-
tein source (dairy vs. nondairy) in diets that contain moderate
amounts of protein. We hypothesized that the optimal condition
for a high ratio of fat:lean mass loss would occur in the indi-
viduals who consumed higher protein and a greater amount of
dairy foods.
Methods
Participants. Our study, the Improving Diet, Exercise and Lifestyle
(I.D.E.A.L.) for Women Study, was approved by the Research Ethics
Board of the Hamilton Health Sciences and conformed to the most recent
Canadian government tri-council funding policy statement on the use of
humansubjectsinresearch(33). Thestudywas conductedfromJune 2008
to May 2010. A total of 246 women were recruited from McMaster
University and the surrounding Hamilton area through posters and local
newspaper advertisements. Of those, 95 participants gave their written,
informed consent to participate. Prior to beginning the trial, 5 women
declinedparticipationand90wererandomizedinto3groups.Information
regarding recruitment and participant ﬂow is in Supplemental Figure 1.
Participants were all premenopausal and overweight or obese women
(BMI between 27 and 40 kg/m
2) between the ages of 19 and 45 y. Other
general inclusion criteria were: low dairy product consumption, sedentary
lifestyle, regular menstrual cycle, no vitamin or mineral supplementation,
and otherwise healthy. Participants were deemed healthy and eligible to
participate based on their responses to a short medical screening ques-
tionnaire that inquired about metabolic risk factors (cholesterol, insulin,
and glucose concentrations and blood pressure), heart and other organ
disease, orthopedic injury that would interfere with exercise, gastrointes-
tinaldisease,clinicallydiagnoseddairyproteinallergy,clinicallydiagnosed
lactose intolerance, and prescription medication use. Participants were
excluded if they had any of the aforementioned conditions.
Prior to the study commencing, participants’ height and weight were
measured (Healthweigh 140–10 Eye Level Digital Physician scale). They
then completed a FFQ validated for calcium and dairy foods to verify
their low consumption at baseline (as per the study inclusion criteria).
Participantswerealsoinstructedonhowtoaccuratelycompletea7-dfood
record and were given their own set of measuring cups and spoons to use
throughout the study.
Study protocol. Participants were randomly assigned to 1 of 3 groups:
adequate protein, low dairy (APLD)
8, adequate protein, medium dairy
(APMD); or high protein, high dairy (HPHD). The randomization was
stratiﬁed by BMI (27–29, 30–34, and 35–40 kg/m
2), the most commonly
used criterion for classiﬁcation of overweight/obesity, to ensure that an
equal number of participants from each BMI category were in each
treatment group. Our stratiﬁcation scheme was adequate, because there
were no between-group differences in any baseline variable. The 3 groups
differed in the amount and type of protein consumed and their dietary
macronutrient distribution. The APLD group maintained their stable
baseline dairy food consumption at ,2% energy/d from dairy protein
correspondingto0–1 serving/d [1dairyserving represents250mL ofmilk,
50 g cheese, or 175 mL of yogurt according to Canada’s Food Guide (34),
and 250 mL of milk or yogurt and 45 g of cheese according to the USDA
Food Pyramid (35)]. The APMD group was instructed to consume 7.5%
energy/d from dairy protein at 3–4 servings/d of dairy products and the
HPHD group to consume 15% of energy/d from dairy protein at 6–7
servings/d of dairy products. All dairy products needed to control dairy
and calcium intakes were provided to participants in the APMD and
HPHD groups and were generously donated by Agropur Dairy Cooper-
ative (Table 1). The APLD and APMD groups consumed a diet consisting
of 55:30:15 (percent energy from carbohydrate, fat, and protein) and the
HPHD group consumed a diet consisting of 40:30:30. Thus, the studywas
designed such that the HPHD group consumed twice the amount of
protein (and lower carbohydrate) than the other 2 groups and twice the
amount of dairy foods as the APMD group. The APMD group consumed
the same amount of protein as the APLD group (15%), with one-half of
that protein from dairy sources and the other one-half from high-quality
nondairy sources such as lean red meat, eggs, ﬁsh, chicken, pork, legumes,
soy, and wheat. The APLD group was counseled to consume all protein
from the same nondairy sources mentioned above. All participants were
prescribed the same exercise regimen and underwent individual biweekly
dietary counseling during the 16 wk.
Maintenance energy requirements were calculated per participant
using the Mifﬂin St Jeor equation (36) with a sedentary activity factor.
Once this energy level was determined, it was reduced by 500 kcal/d and
used as the participant’s targeted total energy intake throughout the study;
thus, all women consumed a hypoenergetic diet.
All groups consumed 2 study drinks/d; one immediately postexercise
and another drink at least 5 h before or after exercise. Each drink was 375
mL and was prepared daily in opaque, reusable, plastic bottles. Bottles
were prepared and labeled for each participant by study staff in our
metabolic kitchen. All drinks provided similar energy and were chocolate
ﬂavored so that they looked, smelled, and tasted similar to keep the
participants unaware of their contents. Known to study staff only, the
drinks were either 1% chocolate milk (APMD); Splenda-sweetened 1%
chocolate milk (HPHD) (Table 1); or a custom-blended, nondairy, vitamin
D- and calcium-free, carbohydrate-based, chocolate-ﬂavored beverage
(APLD). Splenda-sweetened chocolate milk was provided to the HPHD
group to keep their carbohydrate intake from study foods low. This
enabled them to consume their restricted level of dietary carbohydrate
(40%) from other food sources (e.g. fruits, vegetables, and whole grains).
All participants received individualized diet counseling by study
dieticians and research nutritionists on a biweekly basis. The initial 7-d
food record was analyzed using ESHA (Food Processor SQL, ESHA
Research) (37) and it served as the starting point for which the diet
counseling was based. Each participant was provided with an individu-
alized plan outlining their required macronutrient intakes in grams
corresponding to their new daily energy requirements and the respective
macronutrient distribution of the group to which they were randomized.
8 Abbreviations used: AMDR, acceptable macronutrient distribution range;
APLD, adequate protein, low dairy; APMD, adequate protein, medium dairy;
CRP, C-reactive protein; HPHD, high protein, high dairy; HR, heart rate; I.D.E.A.
L., Improving Diet, Exercise, and Lifestyle for Women Study; VAT, visceral
adipose tissue.
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compliance with the nutrition protocol. All 3-d food records were
analyzed with ESHA and participants were provided with feedback in
their next biweekly private counseling session. To ensure that the results
were due as much as possible to the differing dietary components, par-
ticipants were instructed not to take any vitamin or mineral supplements
during the study.
Exercise training. Participants exercised in our own exercise and
testing center and at the main ﬁtness center at McMaster University.
They engaged in various modes of aerobic exercise every day, 5 d/wk
with us and 2 d on their own on the weekend. At each workout
participants were to expend 250 kcal. During the week (Monday–
Friday), they reported to our study ofﬁce daily and were often given a
SenseWear Pro energy expenditure device (BodyMedia) to wear,
programmed for them, so they could track their energy expenditure
during their workout. Compliance with weekend workouts was assessed
by having women take home and wear the SenseWear Pro device on
random occasions. In addition to aerobic exercise, participants engaged
in a progressive resistance training regimen 2 d/wk (upper body, lower
body split) with trained study personnel (personal trainer or kinesiol-
ogist). Weight lifted by each participant was recorded every session and
increased once they could complete 3 sets of 10 repetitions or more at
any given weight. The majority (i.e. ;70%) of the aerobic exercise
sessions were individually or small-group (i.e. 1 trainer to 2–3 partic-
ipants) supervised and all of the resistance exercise sessions were
individually supervised. Resistance exercise logs were completed by the
trainer and aerobic exercise logs were completed by the participant and
checked frequently by study personnel to ensure compliance.
Body composition. Whole-body DXA scans (QDR-4500A; Hologic,
software version 12.31) were carried out at wk 0, 8, and 16 to determine
total body weight, fat mass, and (fat and bone free) lean mass. Women
were scanned wearing light clothing at the same time of day and were
instructed to follow the same prescan diet and exercise instructions before
each scan. After study completion, pre- and poststudy DXA scans were
further analyzed for the determination of trunk fat. The abdominal region
of interest on all scans was isolated between the lumbar vertebrae L1–L4
by the same trained individual and fat mass was recorded. Investigators
were unaware of the participants’ group assignment during analysis.
Asubsetofwomen(n=39)underwentMRimaging(3TSignaScanner,
GE Healthcare) at wk 0 and 16 to directly ascertain the change in VAT
volume during the intervention. Of these 39 women, 8/12 in the APLD
group, 8/13 in the APMD group, and 9/14 in the HPHD group were
Caucasian. MRI scans were performed on the participants’ torso region
from the top of their liver to the iliac crest (determined by an axial scan),
corresponding to 3 sectional scans of 10–12 slices each. Participants were
instructed to hold their breath after exhalation for the duration of the
sectional scan (;20 s each) to ensure that the movement of breathing did
not adversely affect the quality of the image. The MR images were
analyzed with Santesoft Medical Imaging software (Sante DICOM Editor)
using a standardized tracing protocol. To reduce variability, all scans were
analyzed by the same trained and blinded technician who, on random
scans, showed an inter-scan variability of ,5%.
Strength and aerobic ﬁtness testing. Strength was tested by
determining each participant’s single lift voluntary maximal strength or
1repetitionmaximumonthelegextension,hamstringcurl,seatedrow,and
chest press pre- and postintervention. All testing was done bytrained study
personnel using the same standardized protocol described elsewhere (31).
Aerobic ﬁtness was measured using a modiﬁed Astrand submaximal
ﬁtness test protocol (38). Participants were asked to cycle on a stationary
bicycle (Monark Ergomedic 828E, HealthCare International) at 2 con-
secutive workloads for 6 min each and HR was recorded every minute.
Anthropometry. Waist and hip circumference was measured 3 times
throughout the study: at wk 0, 8, and 16. We used the circumference of
the waist at the participant’s umbilicus as the site of measure. Two
separate research assistants took measurements independently with the
same tape measure (Gulick II Tape Measure, FitnessMart) and the 2
measurements were averaged. The average difference between the 2
measures was always ,1.5 cm.
Blood samples and laboratory analyses. Blood samples were
obtained on 2 occasions (pre- and postintervention) between 0630 and
1000 h after an overnight fast of 10–12 h in tubes containing either
sodium heparin or no additives to obtain plasma and serum, respectively.
Serum insulin (chemiluminescent microparticle immunoassay; Architect
System, Abbott Laboratories) and lipids and plasma glucose and calcium
(colorimetric assay; Roche COBAS MIRA Clinical Analyzer, Roche
Diagnostics) were analyzed at the Core Laboratory at the McMaster
UniversityMedicalCentre. The remainingsampleswere storedat 2208C
for later analysis. At study completion, serum samples were batch-
analyzed for IL-6 (high sensitivity ELISA; R&D Systems) and CRP
(ELISA; ALPCO Immunoassays). All investigators and laboratory techni-
cians were unaware of the participants’ group assignment during analysis.
Statistics. Statistical analyses were performed usingSPSS(version18.0).
Prior to hypothesis testing, primary endpoint data were examined for
normality. Non-normally distributed variables were log-transformed
before analysis. Analysis was conducted on all participants who
completed the study as well as on those who did not complete (all of
whom dropped out after 8 wk). In accordance with recently suggested
practices for randomized weight loss trials (39), we conducted an intent-
to-treat analysis where missing data values were imputed using model-
based multiple imputation. Differences between groups in all baseline
TABLE 1 Nutritional information of the dairy foods provided to the participants in the adequate
protein, medium dairy (APMD) and high protein, high dairy (HPHD) groups in the Improving
Diet, Exercise and Lifestyle for Women Study, including the products used, the quantities
of dairy foods consumed, and their nutritional contents
Quantity Energy
1 Calcium Vitamin D Protein
kcal mg mgg
APMD
1% chocolate milk (Sealtest)
2 3 x 250 mL 450 750 6.8 21
Source yogurt (Yoplait) 2 x 100 g 70 200 1.5 8
Total amount 520 950 8.3 29
HPHD
1% Splenda-sweetened chocolate milk (Sealtest)
2 3 x 250 mL 300 750 6.8 21
1% white milk (Sealtest) 1 x 250 mL 100 300 2.3 9
Source yogurt (Yoplait) 4 x 100 g 140 400 3.0 16
Cheddar cheese (Bright Bites) 2 x 21 g 180 200 0.0 10
Total amount 720 1650 12.1 56
1 1 kcal = 4.18 kJ.
2 Chocolate milk used as the study drinks for the APMD and HPHD groups.
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P , 0.05. Data in the text are means 6 SE.
Initial analysis was performed using a 2-way, repeated-measures
ANCOVA with baseline bodyweight as the covariate for the primary
outcome variables. Two-way, repeated-measures ANOVA was also
performed on the change values (wk 0–8 and 8–16) for the primary
outcome variables and waist circumference. Signiﬁcant F ratios were
further analyzed using planned contrast ANOVA (repeated measures or
univariate) to determine differences both within and between groups,
respectively. Signiﬁcant differences were isolated with Tukey’s post hoc
test with a Bonferroni correction for multiple comparisons. Pearson
correlation coefﬁcients were also calculated for several measures. The
MRI portion of the study was carried out on a smaller cohort of women
(n = 39; 12 in APLD, 13 in APMD, and 14 in HPHD); therefore, only
these women were included in the MRI statistical analysis.
Results
Participants. Ninety women participated in this study. Nine
participants (6 in the APLD group and 3 in the HPHD group)
dropped out after wk 8 (half-way) for reasons unrelated to
the study (Supplemental Fig. 1). The participants represented a
multiracial/multiethnic population with n = 15 (APLD), n =1 3
(APMD), and n = 18 (HPHD) Caucasian women in each group.
The other women were East Indian (n = 15), Asian (n = 9),
African, African American, Native Canadian, Portuguese, Eu-
ropean, or Hispanic and were equally distributed throughout the
groups. None of the baseline values for any variables studied
signiﬁcantly differed between the groups (Table 2).
Body composition (DXA). Total body mass decreased by sim-
ilar amounts across all groups over time with no differences
between groups (pooled mean change over time: 24.3 6 0.7 kg;
P , 0.05).The loss of body fat in all groups wassigniﬁcant when
expressed in kilograms and percent of initial weight (P , 0.01),
but the fat mass and percent fat reductions in the latter half of
the study (wk 8–16) in the HPHD group were signiﬁcantly
greater than in the other 2 groups (Fig. 1). The loss of percent fat
expressed as the change from baseline in the HPHD group was
similar in the ﬁrst and second halves of the study. Lean mass
increased over the 16 wk in the HPHD group (0.7 6 0.3 kg; P ,
0.05), remained unchanged in the APMD group (20.2 6 0.2
kg), and decreased in the APLD group (20.7 6 0.3 kg; P ,
0.05). During the latter half of the study, the accretion of lean
mass in the HPHD group was greater than in the APLD (P ,
0.01) and APMD groups (P , 0.05). DXA-determined trunk fat
mass [regional analysis of L1–L4; a surrogate measure of VAT
(40)] decreased in all groups (P , 0.05), with the HPHD group
losing more trunk fat than the APLD group (P , 0.005; Fig. 2A).
VAT volume (MRI). All groups had a reduction in VAT volume
over time (P , 0.05); however, the HPHD group lost more VAT
than the APLD group (P , 0.05; Fig. 2B). The change in trunk fat
mass, obtained by DXA, was correlated with the change in MRI
VAT measured in the same women (Fig. 2C). This indicates that
determination of changes in trunk fat mass by DXA in this pop-
ulation provides a reasonable proxy measure for changes in VAT.
Strength and ﬁtness. Allgroups improved their strengthfor all
exercises over time (Table 3). The HPHD group had greater
strength atwk 16than the APLDgroup inthe seated row andthe
hamstring curl (P , 0.05) and a tendency for greater strength in
the chest press (P = 0.059). Cardiovascular ﬁtness improved
similarly in all groups with a mean HR reduction pre- to
postintervention of ;15 bpm (P , 0.05).
Anthropometry. BMI decreased across all groups over time
with no differences between groups (pooled mean change over
time: 21.8 6 0.3 kg/m
2; P , 0.05). Waist circumference also
decreased in all groups throughout the study (pooled mean
change over time: 24.9 6 0.9 cm; P , 0.05). When expressed as
change from baseline, that in the APLD group during the latter
half of the study (20.6 6 0.8 cm; wk 8–16) was less than that
during the ﬁrst half (24.2 6 1.0 cm; wk 0–8; P , 0.05). On the
other hand, both the APMD (23.0 6 0.7 and 21.8 6 0.7 cm)
and HPHD (23.2 6 0.8 and 21.9 6 0.7 cm) groups showed
similar signiﬁcant reductions in waist circumference in the
earlier and later halves of the study.
Blood results. IL-6 decreased over time in the APMD group
(20.39 6 0.27 ng/L; P , 0.05) and tended to decline in the
HPHD group (20.37 6 0.12 ng/L; P = 0.071). There was no
change in the APLD group (20.10 6 0.14 ng/L). CRP decreased
in all groups over time with no differences between groups
(pooled mean change over time: 22.32 6 0.66 mg/L; P , 0.05).
Baseline levels in all groups for glucose, insulin, cholesterol
(total, LDL, and HDL), and TG were within normal ranges
(41,42) and did not signiﬁcantly differ from one another (Table
2). During the study, total cholesterol, LDL cholesterol, and TG
decreased in the HPHD and APLD groups (P , 0.05). Insulin
levels decreased in the APMD group (P , 0.05). Plasma calcium
remained unchanged during the study in all groups (Supple-
mental Table 1).
Diet. Baseline diets were analyzed from the prestudy 7-d food
records. Calcium intake at the start of the study was approx-
imately one-half of the recommended intake (43) (Table 2) and
did not differ between groups. At study entrance, participants
were consuming close to the RDA for protein (44) (Table 2),
which corresponded to a mean intake of 15% of daily energy
from protein across all groups. Carbohydrate consumption in all
groups was ;52% and fat was ;31% (Table 2).
Calcium intake at wk 16 (which reﬂected dietary intakes
throughout the study; Table 4) correlated with changes in percent
body fat (r =0 . 2 1 ;P , 0.05), trunk fat mass (r =0 . 3 0 ;P , 0.01),
and VAT volume (r =0 . 4 0 ;P , 0.01). Protein consumption at wk
16 (expressed as a percentage of daily energy intake; Table 4) was
also correlated withchanges inbodyfat mass(r =0 . 2 2 ;P , 0.05),
percent body fat (r=0 . 2 5 ;P ,0.05),trunkfatmass(r =0. 3 3;P ,
0.005), and VAT volume (r = 0.32; P , 0.05).
Discussion
In overweight and obese premenopausal women, signiﬁcantly
greater fat loss accompanied by a gain in lean (muscle) mass was
achieved during a 16-wk hypoenergetic period, mediated by diet
(2500 kcal/d) and exercise (2250 kcal/d), that provided higher
dietary protein (30% of total energy intake) within the AMDR
(44), with one-half of the total dietary protein intake from dairy
foods. Although all treatment groups lost a signiﬁcant amount of
trunk fat, higher dairy food and dietary protein consumption
were associated with signiﬁcantly greater reductions in trunk fat
mass and VAT volume than those consuming no dairy foods and
lower protein despite undergoing the identical exercise regimen.
Reductions in trunk fat mass were reﬂected in reduced waist
circumferences, which were also greater in the APMD and
HPHD groups compared to the APLD group. The observed
greater fat loss and the increase in lean mass in the HPHD group,
in the face of similar weight loss across all groups, highlights the
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vention in support of our original hypothesis. Because all groups
performed resistance exercise (2 d of 7 d/wk), which is a potent
stimulus for skeletal muscle anabolism (32,45,46), our results
likely represent a loss of skeletal muscle (lean) tissue that was
minimized in the APLD and APMD groups (3,32) but that
translated into a gain, with a measurably greater strength gain,
in the HPHD group.
Favorable associations between dairy food consumption and
adiposity, weight loss, body compositional change, prevention
of weight gain, and a decreased incidence of insulin resistance
and other metabolic syndrome risk factors have been reported in
observational studies and population surveys (47–49). Data
from a recent meta-analysis also emphasizes the beneﬁt of
calcium on body weight in premenopausal women (25), and
clinical trials highlight a possible threshold effect for calcium
intake such that those with habitual calcium intake levels .
;600–700 mg/d do not seem to derive the same body compo-
sition effect from calcium consumption as those with lower
baseline intakes (50,51). Thus, as an entrance criterion, using a
FFQ and baseline food records, we measured and veriﬁed that our
participants were consuming ,555 mg/d calcium at study entry.
As such, our data can still be generalized to North American
women, of whom a large percentage, according to the NHANES
TABLE 2 Baseline characteristics of participants in the Improving Diet, Exercise and Lifestyle for
Women Study
1,2
Variable APLD APMD HPHD
Body composition
BMI, kg/m
2 31.5 6 0.6 31.8 6 0.6 31.4 6 0.6
Height, cm 163 6 1 164 6 1 166 6 1
Age, y 28 6 12 6 6 13 0 6 1
Body weight, kg
DXA 84.0 6 2.1 85.3 6 2.1 87.1 6 2.1
Scale 83.8 6 2.1 85.2 6 2.0 86.7 6 2.2
Fat mass, kg 33.1 6 1.4 34.8 6 1.2 35.5 6 1.3
Body fat, % 39.1 6 0.9 40.6 6 0.7 40.5 6 0.6
Lean mass, kg 48.5 6 1.1 48.2 6 0.9 49.2 6 0.9
Waist circumference, cm 99 6 2.2 102 6 1.80 102 6 2.01
Waist:hip ratio 0.86 6 0.01 0.88 6 0.01 0.87 6 0.01
Trunk fat, DXA, kg 3.3 6 0.2 3.8 6 0.2 4.0 6 0.3
Visceral fat,
3 MRI, cm
3 655 6 80.0 796 6 77.2 666 6 43.6
HR in fitness test
1st workload, HR, bpm kp
4 = 1.2; 138 6 3 kp = 1.2; 141 6 3 kp = 1.3; 139 6 3
2nd workload, HR, bpm kp = 1.9; 166 6 3 kp = 1.8; 163 6 3 kp = 2.1; 167 6 3
Daily dietary intakes
5
Carbohydrate
g 234 6 9 243 6 8 250 6 9
% of total energy 51 6 15 3 6 15 3 6 1
Protein
g 69 6 36 6 6 36 9 6 4
g/kg body weight 0.81 6 0.05 0.78 6 0.03 0.80 6 0.05
% of total energy 16 6 11 4 6 11 5 6 1
Fat
g 68 6 46 5 6 36 3 6 4
% total energy 33 6 13 1 6 13 0 6 1
Energy
MJ (Mcal) 7.66 6 0.31 (1.83 6 0.07) 7.63 6 0.22 (1.82 6 0.05) 7.69 6 0.33 (1.84 6 0.08)
kJ/kg body weight 92 6 4.1 90 6 3.1 90 6 4.4
Calcium, mg 555 6 39 480 6 26 520 6 28
Vitamin D, mg 1.4 6 0.2 1.7 6 0.3 1.7 6 0.3
Blood analytes
Glucose, mmol/L 4.9 6 0.1 4.9 6 0.1 4.9 6 0.1
Insulin, pmol/L 57 6 76 9 6 85 1 6 6
Hemoglobin A1c, % 5.6 6 0.2 5.4 6 0.1 5.4 6 0.1
Cholesterol, mmol/L
Total 4.72 6 0.15 4.48 6 0.11 4.67 6 0.15
LDL 2.75 6 0.13 2.58 6 0.09 2.77 6 0.13
HDL 1.40 6 0.05 1.39 6 0.05 1.43 6 0.05
TG, mmol/L 1.10 6 0.07 1.11 6 0.07 1.00 6 0.07
1 Values are means 6 SE, n = 90 (30/group) unless otherwise noted.
2 APLD, adequate protein, low dairy; APMD, adequate protein, medium dairy; HPHD, high protein, high dairy; HR, heart rate.
3 n = 39: 12 in APLD, 13 in APMD, 14 in HPHD.
4 kp = Kilopond; 1 kp at 50 rpm = 50 watts; 1.5 kp = 75 watts; 2 kp = 100 watts.
5 From baseline 7-d food records.
1630 Josse et al.(52,53) and the Canadian Community Health Survey (54), do not
consume adequate calcium and are overweight or obese (55).
The decision to use dairy foods in this trial was premised on
evidence demonstrating that consumption of calcium from dairy
foods as opposed to elemental calcium, with energy restriction,
has a greater effect on weight loss and body composition in
humans (56,57). The greater fat loss observed with dairy foods
compared to calcium supplementation may relate to the fact that
dairy foods contain other bioactive components acting indepen-
dently or synergistically with calcium and vitamin D to enhance
fat loss. In premenopausal obese women consuming low-fat milk
(providing 1200 mg/d calcium) on an 8-wk energy-restricted diet,
greater reductions were observed in weight, BMI, and waist:hip
ratio than in groups who consumed calcium carbonate or a soy
beverage with equal amounts of calcium (56). The authors con-
cluded that the additional effect observed with milk consumption
likely related to other bioactive components such as the protein
fraction rich in branched-chain amino acids (leucine, isoleucine,
and valine) (58). Other effects of calcium and dairy foods that
could potentially be contributing to a greater fat loss include an
increased fecal fat excretion (59), a decrease in fat absorption
(60), increase in fat oxidation (61), and an increased thermic
effect of food (62).
In vitro mechanisms have been shown to exist in adipocytes
that support an antiadipogenic and prolipolytic effect of dairy
components, including leucine and calcium (26,63,64). Similar
effects have been demonstrated in rodents (65,66). These
mechanisms may help to explain the greater total and visceral
fat mass loss experienced by those women consuming the most
dairy foods and dairy-derived calcium (the HPHD group).
Interestingly, it may not require an energy deﬁcit to see such
effects. We have reported similar effects under anabolic condi-
tions (i.e. energy surplus with intense resistance training) in
young women consuming an additional 1 L/d of low-fat milk
(31). Our trial design featured changes in consumption of whole
foods with varying contents of macronutrients to affect fat loss
as opposed to isolated individual nutrients that comprise dairy;
thus, the signiﬁcance of calcium per se as a causative factor in fat
lossis hard to determine. However,we alsoobserved thatdietary
calcium intakes during the study were signiﬁcantly correlated
with changes in percent body fat and visceral fat assessed by
both DXA and MRI, which is similar to the relationships
between calcium intake and fat loss during energy restriction
reported by others (26,63,64). Reductions in inﬂammatory
biomarkers (CRP and IL-6), which also may relate to visceral fat
loss, were seen in all groups, with the HPHD and APMD groups
having greater reductions in IL-6 than the APLD group.
The consumption of higher protein (lower carbohydrate)
compared to conventional protein (i.e. 15% of energy) with
energy restriction has yielded mixed results with respect to
weight loss and several studies have shown that the macronu-
trient composition of a weight loss diet does not seem to matter
as much as compliance to the regimen itself (11–13). However,
when assessing the effect of weight loss diets with different
macronutrient ratios on hypoenergetic-induced changes in body
composition, higher protein diets appear to be advantageous. In
a meta-analysis (14), energy restriction (without exercise) with
higher protein intakes [125% of the protein RDA (44)] were
associated with a greater lean mass retention than studies where
protein consumption was at the RDA (44). In our study, the
HPHD group consumed ;1.3 g/(kg×d) protein for 16 wk (Table
4), which could have contributed to the lean mass gain in this
group. In addition, the protein and carbohydrate intakes of the
HPHD group (;30 and 40% daily energy intake, respectively)
were not as excessive as those employed in more extreme
protocols (11,12) and they were close to intakes recommended
in the AMDR (44). Of note (and not by design), during the study
the APLD group was consuming protein at a level slightly below
the RDA (44) (Table 4) and an additional 0.08 g/(kg×d) cor-
responding to ;8 g/d of protein would have rectiﬁed this. How-
ever, it has been suggested that even protein intakes around the
RDA may be insufﬁcient during weight loss to spare muscle mass
FIGURE 1 Absolute (A,C,E) and relative-to-baseline (B,D,F) changes in body fat mass (A,B), percent body fat (C,D), and lean mass (E,F)
in overweight and obese premenopausal women who underwent a 16-wk intervention of diet- and exercise-induced weight loss. Values are
means 6 SE, n = 90 (30/group). Means at a time without a common letter differ, P , 0.05. *Different from the preceding time point, P , 0.05.
APLD, adequate protein, low dairy; APMD, adequate protein, medium dairy; HPHD, high protein, high dairy.
Dairy foods, dietary protein, and body composition 1631(16). Nevertheless, protein intake in the APLD group did cor-
respond to 16% of their daily energy intake, which is within the
AMDR (10–35%) (44) and at the appropriate a priori level per
the study protocol. Other studies have assessed the combined
effect of high protein and physical activity during a period of
hypoenergetic weight loss (17,19) and reported that exercise
does not actually affect total weight loss; however, exercise
increases fat mass loss and also promotes lean mass retention
greater than that seen with the intake of higher protein alone
(17), which parallels our observations (17,19).
With 16 wk of training composed of both aerobic and
resistance exercise, strength and ﬁtness increased substantially
in all groups. HR reductions at the same absolute workload
averaged 15 bpm, which is indicative of a clinically meaningful
increase in aerobic ﬁtness. Improvements in cardiovascular ﬁt-
ness show a strong negative association with all-cause mortality
in women (67); therefore, the importance of the increase in
ﬁtness shown here should not be overlooked. Insofar as mus-
cular strength is concerned, although gains were evident in all
groups for all exercises performed, the HPHD group had greater
increases in strength in various exercises (seated row, hamstring
curl) compared to the APLD group (Table 3). It is entirely
possible that these strength gains relate to the body composition
changes in that the group that lost muscle mass (the APLD
group, albeit minimal) had the most modest improvements in
strength, whereas those that lost no muscle (the APMD group)
or even gained muscle (the HPHD group) showed greater im-
provements. The improvement or even preservation of muscle
function with weight loss could have important implications
in populations such as the elderly, in whom muscle mass pre-
servation is critical. Similar results for strength gains were dem-
onstrated in a previous study performed in our laboratory in
women consuming milk compared to anisoenergetic carbohydrate-
containing drink post resistance exercise (31).
In summary, higher intakes of dietary protein and dairy
foods, during dietary energy restriction combined with an
exercise intervention, improved the composition of weight lost
compared to those who consumed diets lower in protein and
lower or devoid of dairy foods. We observed what we view as a
highly beneﬁcial proﬁle of weight loss in the HPHD group:
greater total fat and visceral fat losses, greater lean mass gains,
and increases in strength despite identical body weight loss.
Correlations between self-reported dietary calcium and protein
intakes with total fat, and DXA- and MRI-derived trunk/visceral
fat losses indicate potential mechanisms of action for these
nutrients in fat loss. Our data suggest that higher protein intakes
with an emphasis on increased intakes from dairy foods, modest
energy restriction, and combined aerobic and resistance training
result in favorable body composition, strength, and ﬁtness
changes that are not captured by simple measures of body
weight or BMI. These data provide evidence for the promotion
of low-fat dairy food consumption not only to ensure adequate
calcium intakes in populations previously deﬁcient (52–54), but
to promote the provision of high-quality protein that can aid in
fat loss and lean mass retention during energy restriction.
FIGURE 2 Relative to baseline changes in trunk fat mass measured
by DXA (A) and visceral fat volume measured by MRI (B) in overweight
and obese premenopausal women who underwent a 16-wk intervention
of diet- and exercise-induced weight loss, and the correlation between
the 2 measures (C). Values are means 6 SE, n = 39. Means without
a common letter differ, P , 0.05. *Different from wk 0, P , 0.05. APLD,
adequate protein, low dairy; APMD, adequate protein, medium dairy;
HPHD, high protein, high dairy; VAT, visceral adipose tissue.
TABLE 3 Single repetition voluntary strength test results from overweight and obese premenopausal
women before and after a 16-wk intervention of diet- and exercise-induced weight loss
1,2
APLD APMD HPHD
Variable wk 0 wk 16 wk 0 wk 16 wk 0 wk 16
kg
Seated row 34 6 13 6 6 1
a*3 5 6 14 0 6 1
b*3 5 6 14 1 6 1
b*
Chest press 28 6 23 0 6 1* 28 6 23 3 6 1* 28 6 13 4 6 1*
Leg extension 77 6 38 9 6 3* 79 6 38 9 6 3* 80 6 39 5 6 3*
Hamstring curl 46 6 25 2 6 2
a*4 9 6 25 5 6 2
a,b*4 9 6 25 8 6 2
b*
1 Values are means 6 SE, n = 90 (30/group). Means at a time with superscripts without a common letter differ, P , 0.05. *Different from
wk 0, P , 0.01.
2 APLD, adequate protein, low dairy; APMD, adequate protein, medium dairy; HPHD, high protein, high dairy.
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